engleski

Cardiac arrhythmia as a side effect of ketanserin therapy in a patient with systemic scleroderma

Systemic scleroderma (SS) may involve almost every parenchymal organ or system, including cardiovascular, myocardium, pericardium, and conduction system of the heart. Although the impact of SS on cardiac function has long been known, its prevalence and prognosis have only recently been more extensively investigated and better understood. In most patients, cardiac involvement is subclinical ; however, the prognosis is very poor in those that develop overt symptoms and complications.

Cardiac arrhythmia ; ketanserin ; systemic scleroderma

nije evidentirano